Citius Pharmaceuticals, Inc. (CTXR): Price and Financial Metrics
CTXR Price/Volume Stats
Current price | $2.61 | 52-week high | $26.75 |
Prev. close | $2.62 | 52-week low | $2.44 |
Day low | $2.60 | Volume | 3,622 |
Day high | $2.68 | Avg. volume | 97,421 |
50-day MA | $3.17 | Dividend yield | N/A |
200-day MA | $11.55 | Market Cap | 22.43M |
CTXR Stock Price Chart Interactive Chart >
Citius Pharmaceuticals, Inc. (CTXR) Company Bio
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. The company is developing Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter, which is in Phase III clinical trials; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
CTXR Price Returns
1-mo | -26.69% |
3-mo | -47.80% |
6-mo | -82.69% |
1-year | -86.47% |
3-year | -93.22% |
5-year | -90.51% |
YTD | -34.75% |
2024 | -78.85% |
2023 | -4.24% |
2022 | -48.70% |
2021 | 50.98% |
2020 | 0.00% |
Loading social stream, please wait...